News
Abbott to sell its developed markets branded generics pharma business to Mylan
The business to be sold operates in Europe, Japan, Canada, Australia and New Zealand and includes approximately 3,800 employees Abbott will sell its developed markets branded generics pharmaceuticals business to Mylan for equity ownership of a...
News
Glenmark Generics receives final ANDA approval for Telmisartan tablets
Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis Glenmark Generics Inc., US a subsidiary of Glenmark Generics Limited has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration...
News
Rotavirus Vaccination Decreases Diarrhea Hospitalizations Among Kids
Since the introduction of routine rotavirus vaccination in 2006, rates of diarrhea-related hospitalizations in US children have decreased significantly. Diarrhea-related health care use among young children in the United States has dramatically decreased since the implementation...
News
Boehringer Ingelheim Statement on Hepatitis C drug development
Boehringer Ingelheim has re-evaluated its strategy in hepatitis C (HCV), and as a result the company has decided not to move forward in this therapeutic area. The HCV treatment environment has significantly and rapidly evolved since the submission of...
News
US nets biggest penalties for fraud from pharma
The US crackdown on healthcare fraud is paying huge dividends to the exchequer, accounting for three quarters of the money recovered as penalties in fraud cases exposed by whistleblowers between 1987 and 2013-over $21 billion of the total $27...
News
Soon, get HIV tests done at UK supermart
Britons can now get a quick HIV test — in 60 seconds flat, when they visit a supermarket. A British sexual health charity has decided to offer HIV tests at a supermarket in Slough from May 19. The...
News
Takeover drama between Pfizer and AstraZeneca reached PM’s door
The takeover drama of Britain's AstraZeneca by US drugs giant Pfizer has now reached British prime minister David Cameron's doorstep. In a letter to Cameron, Pfizer chief Ian C. Read tried to address concerns over the bid and said...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















